Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - Quantisnow
| COEPW Stock | USD 0.02 0 19.50% |
Slightly above 51% of Coeptis Therapeutics' sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coeptis Therapeutics Holdings suggests that some traders are interested. Coeptis Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Coeptis Therapeutics' earnings reports, geopolitical events, and overall market trends.
Coeptis |
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use Quantisnow
Read at news.google.com
 |
Coeptis Therapeutics Fundamental Analysis
We analyze Coeptis Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coeptis Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coeptis Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Coeptis Therapeutics is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Coeptis Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coeptis Therapeutics stock to make a market-neutral strategy. Peer analysis of Coeptis Therapeutics could also be used in its relative valuation, which is a method of valuing Coeptis Therapeutics by comparing valuation metrics with similar companies.
Peers
Coeptis Therapeutics Related Equities
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.